Officials: Many Health Care Providers In Pa. And Del. Received Tainted Steroids
CBS Philly (con't)
Affordable Care Act Updates: CBSPhilly.com/ACA
Health News & Information: CBSPhilly.com/Health
Get Breaking News First
WILMINGTON, Del (CBS) – The Pennsylvania Department of Health and the Delaware Division of Public Health (DPH) are now saying that many state health care providers received tainted medications from a Massachusetts company linked to the fungal meningitis outbreak.
DPH is advising residents to contact their health provider if they received steroid or joint injections after May 12, 2012.
The move came after the FDA expanded the recall to include all drugs from the New England Compounding Center (NECC) and advised state officials in PA that approximately 140 providers had received the tainted steroids. Thirteen Delaware health care providers also received them.
Officials say the implicated medications may have been administered into joints, the spine or eyes or used during heart surgery.
The following list includes Delaware facilities identified by FDA as having received NECC medications:
Advanced Eye Care PA received injectible drugs
Anesthesia Providers received injectible drugs
Bayhealth Medical Center received non-injectible drugs
Beebe Medical Center received injectible drugs
Richard Bonder, MD, PA received non-injectible drugs
Christiana Health System received injectible drugs
Christiana Spine ASC received injectible drugs
Glasgow Medical Center received non-injectible drugs
Lewes Surgery Center received injectible drugs
Pain Center of Delaware received injectible drugs
Precision Pain and Rehab received injectible drugs
St. Francis Hospital received injectible drugs
Swier Clinic received non-injectible drugs
Individuals with concerns about NECC medications should call DPH’s Bureau of Epidemiology at 1-888-295-5156.
Officials have not yet released the list of health care providers that received the steroids in Pennsylvania.
As of Thursday, no cases of fungal meningitis due to the tainted medication had been confirmed in Delaware. Pennsylvania has one confirmed case of the illness, but none linked to the expanded recall.